Are there certain populations that are at a higher risk of BRCA mutations you should be paying close attention to? Listen to Basser Executive Director Dr. Susan Domchek's interview with ReachMD.

Basser Executive Director Susan Domchek, MD, commented on Congressional candidate Maya Rockeymore Cummings’ decision to undergo a preventive double mastectomy based on her family history of cancer.

Basser Executive Director Susan Domchek, MD, marks 25 years since BRCA1 was first cloned. She explores the advances in the field since that milestone and looks to the future for areas of growth.

Basser Executive Director, Susan Domchek, MD, discusses the results of the MEDIOLA trial in germline BRCA-mutated metastatic breast cancer.

Susan Domchek, MD, Executive Director of the Basser Center, discusses current guidelines and evolving best practices about when to order genetic testing for patients.

WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center, about breast cancer in men, genetic risks, and what patients should know.

Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast.

Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products.

Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.

For the Journal of the American Medical Association, Basser executive director Susan Domchek, MD, and Memorial Sloan Kettering's Mark Robson, MD, discuss limitations around the new United States Preventive Services Task Force guidelines for BRCA genetic testing.

Basser Center genetic counselors and investigators teamed up to analyze publicly available data for genes in which mutations are implicated in germline cancer susceptibility and establish a pipeline to automate clinical referral for evaluation of tumor-only genetic profiling.